REFERENCES
- Vultaggio A, Agache I, A. Akdis C, Akdis M, Bavbek S, Bossios A et al.
Considerations on Biologicals for Patients with allergic disease in
times of the COVID-19 pandemic: an EAACI Statement. Allergy 2020 (in
press).
- Halpin D, Faner R, Sibila O, Badia JR, Agusti A. Do chronic
respiratory diseases or their treatment affect the risk of SARS-CoV-2
infection?
Lancet
Respir Med. 2020 May; 8(5):436-8.
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the
Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a
Report of 72314 Cases From the Chinese Center for Disease Control and
Prevention. JAMA. 2020 April; 323(13):1239-42.
- Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical
characteristics of 140 patients infected with SARS-CoV-2 in Wuhan,
China. Allergy 2020;00:1–12.
- Carli G, Cecchi L, Stebbing J, Parronchi P, Farsi A. Is asthma
protective against COVID-19? Allergy 2020;00:1–3.
- Zhang JJ, Cao YY, Dong X, Wang BC, Liao MY, Lin J, et al. Distinct
characteristics of COVID-19 patients with initial rRt-PCR-positive and
rRt-PCR-negative results for SARS-CoV-2. Allergy 2020;00:1–4.
- Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yan YQ, et al. Eleven faces of
coronavirus disease 2019. Allergy 2020;00:1–11.
- Johnston SL. Asthma and COVID-19: is asthma a risk factor for severe
outcomes? Allergy 2020 (in press).
- Avdeev S, Moiseev S, Brovko M, Yavorovskiy A, Umbetova K, Akulkina L,
et al. Low prevalence of bronchial asthma and chronic obstructive lung
disease among intensive care unit patients with COVID-19. Allergy
2020;00:1–3.
- Plaza V, Fernandez-Rodriguez C, Melero C, Cosio BG, Entrenas LM, de
Llano LP, et al. Validation of “Test of the Adherence to Inhalers”
(TAI) for asthma and COPD patients. J Aerosol Med Pulm Dug Deliv
2016;29:142-52.
- Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al.
Development of the asthma control test: a survey for assessing asthma
control test. J Allergy Clin Immunol 2004;113:59-65.
- Jordan RE, Adab P, Cheng KK. Covid-19: risk factor for severe disease
and death. BMJ 2020;368:m1198.
- Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for
severity and mortality in adult COVID-19 inpatients in Wuhan. J
Allergy Clin Immunol 2020;146(1):110-8.
- Haroun-Díaz E, Vázquez de la Torre M, Ruano FJ, Somoza Álvarez ML,
Pérez Alzate D, López González P, et al. Severe asthma during the
COVID-19 pandemic: Clinical observations.
J Allergy
Clin Immunol Pract 2020 (in press).
- Liu S, Zhi Y, Ying S. COVID-19 and Asthma: Reflection During the
Pandemic. Clin Rev Allergy Immunol. 2020
- Gonzales-van Horn SR, Farrar JD. Interferon at the crossroads of
allergy and viral infections. J Leukoc Biol. 2015 Aug;98(2):185-94.
- Lebre MC, van Capel TM, Bos JD, Knol EF, Kapsenberg ML, de Jong EC.
Aberrant function of peripheral blood myeloid and plasmacytoid
dendritic cells in atopic dermatitis patients. J Allergy Clin Immunol.
2008;122(5):969‐76.
- Richardson PJ, Corbellino M, Stebbing J. Baricitinib for COVID-19: a
suitable treatment? -Authors’ reply. Lancet Infect Dis. 2020 Apr 3.
- Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, et
al. Interferon-mediated immunopathological events are associated with
atypical innate and adaptive immune responses in patients with severe
acute respiratory syndrome. J Virol. 2007 Aug;81(16):8692-706.
- Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, et
al. Dysregulated Type I Interferon and Inflammatory
Monocyte-Macrophage Responses Cause Lethal Pneumonia in
SARSCoV-Infected Mice. Cell Host Microbe. 2016 Feb 10;19(2):181-93.
- Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K, et
al. Inhibitory effects of glycopyrronium, formoterol, and budesonide
on coronavirus HCoV-229E replication and cytokine production by
primary cultures of human nasal and tracheal epithelial cells. Respir
Investig 2020 May; 58(3):155-68.
- Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, et al.
The inhaled corticosteroid ciclesonide blocks coronavirus RNA
replication by targeting viral NSP15. bioRxiv 2020 (in press).
- Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT,
et al. COVID-19 related genes in sputum cells in asthma: relationship
to demographic features and corticosteroids. Am J Respir Crit Care Med
2020;202(1):83-90.
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia
outbreak associated with a new coronavirus of probable bat origin.
Nature 2020;579(7798):270-3.
- Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, et al. ACE2
receptor expression and severe acute respiratory syndrome coronavirus
infection depend on differentiation of human airway epithelia. J
Virol. 2005;79(23):14614-21.
- Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking
Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential
Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). Journal of
Clinical Medicine 2020;9(3).
- Jackson DJ, Busse WW, Bacharier LB, Kattan M, O’Connor GT, Wood RA, et
al. Association of respiratory allergy, asthma and expression of the
SARS-CoV-2 receptor, ACE2. J Allergy Clin Immunol 2020
jul; 146(1):203-6.
- Shi W, Gao Z, Ding Y, Zhu T, Zhang W, Xu Y, et al. Clinical
characteristics of COVID-19 patients combined with allergy. Allergy
2020;00:1-4.
- Rodrigo-Muñoz JM, Sastre B, Cañas JA, Gil-Martínez M, Redondo N, del
Pozo V. Eosinophil Response Against Classical and
Emerging Respiratory Viruses: COVID-19. J Investig Allergol Clin
Immunol 2021; Vol. 31(2) (in press).
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020;395(10223):497-506.
- Lippi G, Henry BM. Eosinophil count in severe coronavirus disease
2019. QJM 2020 Jul;113(7):511-2.
- Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during
COVID-19 infections and coronavirus vaccination. J Allergy Clin
Immunol 2020;146(1):1-7.
- Jesenak M, Banovcin P, Diamant Z. COVID-19, chronic inflammatory
respiratory diseases and eosinophils – Observations from reported
clinical case series. Allergy 2020. (in press).
- Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M,
Alves-Correia M, el al. A compendium answering 150 questions on
COVID-19 and SARS-CoV-2. Allergy 2020. (in press).